Trials / Unknown
UnknownNCT02873468
Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
Randomized, Double-blind, Multicentric, Parallel, National, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of three doses of Florence oral suspension on changes of eosinophilic infiltration in esophageal biopsies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Florence 30 μg/mL | 10 mL, oral, twice a day. |
| DRUG | Florence 60 μg/mL | 10 mL, oral, twice a day. |
| DRUG | Florence 90 μg/mL | 10 mL, oral, twice a day. |
| OTHER | Placebo | 10 mL, oral, twice a day. |
Timeline
- Start date
- 2021-04-19
- Primary completion
- 2025-07-01
- Completion
- 2025-11-01
- First posted
- 2016-08-19
- Last updated
- 2023-02-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02873468. Inclusion in this directory is not an endorsement.